GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Modular Medical Inc (NAS:MODD) » Definitions » Free Cash Flow

Modular Medical (Modular Medical) Free Cash Flow : $-15.56 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Modular Medical Free Cash Flow?

Modular Medical's total free cash flow for the months ended in Dec. 2023 was $-4.46 Mil. Its total free cash flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-15.56 Mil.

Modular Medical's Free Cash Flow per Share for the months ended in Dec. 2023 was $-0.20. Its free cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.10.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -16.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -49.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Free Cash Flow Growth Rate using Free Cash Flow per Share data.

During the past 13 years, Modular Medical's highest 3-Year average Free Cash Flow per Share Growth Rate was -16.70% per year. The lowest was -135.80% per year. And the median was -74.90% per year.


Modular Medical Free Cash Flow Historical Data

The historical data trend for Modular Medical's Free Cash Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modular Medical Free Cash Flow Chart

Modular Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Free Cash Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.89 -4.36 -6.02 -10.32 -12.65

Modular Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Free Cash Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.15 -3.89 -3.58 -3.62 -4.46

Modular Medical Free Cash Flow Calculation

Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company.

Modular Medical's Free Cash Flow for the fiscal year that ended in Mar. 2023 is calculated as

Free Cash Flow (A: Mar. 2023 )=Cash Flow from Operations+Capital Expenditure
=-11.012+-1.638
=-12.65

Modular Medical's Free Cash Flow for the quarter that ended in Dec. 2023 is calculated as

Free Cash Flow (Q: Dec. 2023 )=Cash Flow from Operations+Capital Expenditure
=-3.965+-0.499
=-4.46

Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Modular Medical  (NAS:MODD) Free Cash Flow Explanation

Free Cash Flow is very close to Warren Buffett's definition of Owner's Earnings, except that in Warren Buffett's Owner's Earnings, the spending for Property, Plant, and Equipment is only for maintenance (replacement), while in the Free Cash Flow calculation, the cost of new Property, Plant, and Equipment due to business expansion is also deducted. There, Free Cash Flow is more conservative than Owner's Earnings.

In Don Yacktman's calculation of forward rate of return, he uses Free Cash Flow for the calculation. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation.

This is what Yacktman said in his March 2012 interview - when the S&P 500 was at 1400:

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over seven years. The reason we use seven years is because research shows that seven years is the length of the typical business cycle.

Therefore, as of Dec23, Modular Medical's Forward Rate of Return (Yacktman) % is

Forward Rate of Return (Yacktman) % (Dec23)=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=0/1.82+0
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Free Cash Flow within a report period can be affected by management's decisions of capital spending. Therefore, it is important to look at long term when it comes to Free Cash Flow.


Modular Medical Free Cash Flow Related Terms

Thank you for viewing the detailed overview of Modular Medical's Free Cash Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Modular Medical (Modular Medical) Business Description

Traded in Other Exchanges
N/A
Address
10470 Thornmint Road, San Diego, CA, USA, 92127
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The company's product's seeks to serve both the type 1 and the rapidly growing especially in terms of device adoption, type 2 diabetes markets.
Executives
Philip Brent Sheibley director C/O MODULAR MEDICAL, INC., 16772 W. BERNARDO DRIVE, SAN DIEGO CA 92127
Manchester Management Co Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02110
Jeb Partners, L.p. other: Director by Deputization MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, BOSTON MA 02114
Kevin Schmid officer: Chief Operating Officer 8 EAGLES NEST LANE, BEDFORD MA 01921
Paul Diperna director, 10 percent owner, officer: See Remarks 16772 W BERNARDO DRIVE, RANCHO BERNARDO CA 92127
Carmen B Volkart director C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Duane M Desisto director INSULET CORPORATION, 9 OAK PARK DRIVE, BEDFORD MA 01730
Ellen O'connor Vos director C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980
Steven G Felsher director C/O SITO MOBILE, LTD.,, 100 TOWN SQUARE PLACE, STE 204, JERSEY CITY NJ 07310
Morgan C. Frank 10 percent owner 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Paul Diperna Irrevocable Trust other: See Footnote(1) 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Stephen Edward Daly officer: Chief Commercial Officer 2090 DIPINTO ROAD, HENDERSON NV 89052
William J Febbo director 600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
Liam Burns director C/O MODULAR MEDICAL, INC., 800 W. VALLEY PARKWAY, SUITE 203, ESCONDIDO CA 92025
James E Besser 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114